The Board of Directors of the International NatGold Council brings together a diverse group of internationally experienced professionals, united in their dedication to fostering a robust global NatGold™ ecosystem.

Steve Moses is Chairman of the International NatGold Council. He is the owner of Geneva-based Parkdale Investments SA, an advisory firm that he founded in 1987. His company invests in a variety of financial instruments and has specialized in raising private and institutional capital for micro and small-cap companies since its inception. Moses was formerly a licensed commodity futures trader at Shearson Lehman Hutton Inc. Before that, he was a trader at ICM Trading and an Account Executive at Trade Development Bank. He has lived in Switzerland since 1970 and brings a wealth of international contacts and experience to the International NatGold Council.

Mark Radke is an esteemed attorney with a rich history in federal securities and financial service legalities. As Chief of Staff at the Securities and Exchange Commission during Chairman Harvey Pitt’s tenure, he played a pivotal role in significant financial events beginning in 2001. He was instrumental in shaping the Sarbanes-Oxley Act, guiding the Commission’s contributions to its legislative foundation and overseeing significant developments in the public accounting sector, leading to the inception of the Public Company Accounting Oversight Board.

Throughout his career, Radke has worked with several premier national and global law firms, serving as a partner or counsel. He has been involved in both civil and criminal enforcement, representing accountants, financial experts, investment professionals, broker-dealers, and corporate leaders in investigations by the SEC, DOJ, FINRA, PCAOB, and state attorneys general. Radke’s expertise also extends to representing insurance and reinsurance firms during domestic and international regulatory probes. His notable involvement includes being part of the litigation team for SEC v. First Jersey Securities.

Radke has served as a corporate monitor for organizations such as the World Bank Group to oversee anti-corruption settlements and was the SEC-appointed monitor following a significant Ponzi scheme incident, providing counsel in the oversight of entities like Paine Webber Group and Prudential Securities. He has advised corporate boards on governance, especially in addressing allegations of corporate misbehavior.

Beyond his legal career, Radke has been a board member and advisor to emerging public corporations and has taught courses on federal securities law enforcement at Georgetown University Law Center since 1999.

Radke earned his B.A. in History from the University of Washington in 1979, his law degree from the University of Baltimore School of Law in 1982, and an L.L.M. in Securities Regulation from Georgetown University Law Center by 1984.

Kate Fehlenberg, MPH, M.S., is a distinguished Climate Change and Scaling Innovations Specialist, with a comprehensive background in regenerative agriculture, climate change resilience, and scaling innovations. Her career showcases significant achievements in climate-smart agriculture, public health, and gender equity, reflecting a deep commitment to ecological and social welfare. Kate’s expertise in strategic planning, project management, and systems change has been crucial in building partnerships, improving operations, and guiding teams towards meaningful results.

Her academic credentials are substantial, possessing an MPH from Columbia University, specializing in Population, Family Health, and Forced Migration, and an MSc in GIS and Sustainable Development from the Georgia Institute of Technology. Additionally, her BSc in Environmental Science and GIS from Samford University enhances her knowledge in environmental systems and sustainability.

Kate’s record of promoting innovations and resilience strategies in demanding settings is proven through her work with esteemed organizations like FHI360, USAID Global Dev Lab, CGIAR, and the Bill & Melinda Gates Foundation. Her leadership in projects across the USA, Kenya, Tanzania, Nepal, and other nations highlights her global outlook and skill in managing complex cultural and ecological contexts.

With fluency in English and proficiency in French, Spanish, Nepali, and Kiswahili, Kate’s language abilities facilitate her interactions with diverse groups and stakeholders, furthering her efforts in climate resilience and regenerative practices. Her career path exemplifies her unwavering commitment to tackling some of the most critical issues of our era, positioning her as an invaluable asset to the Great Eagle team in pioneering a new ESG-conscious future for gold.

Dr. Delon Human, M.B.Ch.B., M.Prax.Med, MFGP, DCH, MBA founded and still serves as president of Health Diplomats, a specialized health, nutrition, and wellness consulting group with clients including Fortune 500 companies, foundations (Rockefeller, Ikea, PepsiCo, McDonalds), governments, NGOs such as the World Medical Association, World Dental Federation, the International Food and Beverage Alliance (IFBA), and universities such as the University of Catania, Italy.

Dr. Human has acted as an advisor to the WHO Director-General and to UN Secretary-General Ban Ki Moon. Until 2014, he served as Secretary-General and Special Envoy to WHO / UN of the International Food and Beverage Alliance, a group of leading food and non-alcoholic beverage companies with a global presence (including companies such as Nestlé, Unilever, PepsiCo, Coca-Cola, McDonalds).

Formerly, Dr. Human was the secretary-general of the World Medical Association (WMA) where he worked closely with the World Health Organization, US FDA, and American Medical Association on matters related to research ethics. He was instrumental in the establishment of the World Health Professions Alliance. In 2006, he was elected Secretary-General of the Africa Medical Association (AfMA). He is a fellow of the Russian and Romanian Academies of Medical Sciences.

Dr. Human was a clinician for two decades, part of the pediatric endocrinology research unit at the John Radcliffe Hospital, Oxford, UK and was involved in the establishment of several medical centers, a hospital, and an emergency clinic in South Africa. Simultaneously, he founded a healthcare insurance company, Human Health Care, which provided strategic planning, medical audits, and consumer care services to around 250,000 insured clients of several health funds.

Dr. Human received his medical qualification in South Africa and completed his postgraduate studies in family medicine and child health in South Africa and Oxford, England. His business studies (MBA) were completed at the Edinburgh Business School.

Simon Langelier, based in Lausanne, Switzerland, adds significant senior executive expertise to the International Green Gold Council, particularly through his leadership roles at Philip Morris International (PMI). From 2002 to 2005, as President of Philip Morris Eastern Europe, the Middle East, and Africa (EEMA), he managed operations across 87 countries, including those in the former Soviet Union, the African continent, and the Middle East. With a team of 8,500 and overseeing annual revenues of $6.9 billion, he was instrumental in strategic market negotiations and expansions in regions such as Russia, Ukraine, South Africa, Iraq, Algeria, Libya, Nigeria, and Senegal.

His executive journey progressed when he served as President of East Asia at Philip Morris Asia Limited in Hong Kong from 2005 to 2007. In this capacity, Langelier directed operations generating annual revenues of $5.7 billion and led a workforce of 3,500 across Japan, Australia, New Zealand, South Korea, and Greater China. His tenure is noted for successful negotiations with the Chinese monopoly that led to a joint venture for the international marketing of Chinese brands and a licensing agreement for Marlboro in China.

From 2007 to 2010, Langelier spearheaded PMI’s Next Generation Products and Adjacent Businesses as President. During this period, he was pivotal in the establishment of the department and significantly expanded PMI’s non-tobacco product line through strategic joint ventures.

Langelier’s governance expertise is also demonstrated through his role as an independent non-executive director at Imperial Brands PLC, where he contributed to the Audit and Succession and Nomination committees until February 2023. Additionally, his tenure as a non-executive board member at Tribeca Asset Management showcases his strategic foresight and oversight, further underscoring his valuable contributions to corporate governance and strategic planning.

Patricia I. Kovacevic, Esq., stands as a global legal and compliance authority in FDA-regulated industries, leading Regulation Strategy with her vast expertise. Her career, spanning over two decades, includes high-ranking legal and regulatory positions at Philip Morris International, Lorillard, and Nicopure Labs. Her tenure at Lorillard is particularly notable for leading the team to secure the FDA’s first-ever premarket tobacco product authorization in 2013, a landmark achievement.

Her involvement didn’t stop there; she played a pivotal role in the strategic acquisitions of blu™️ and Skycig. While at Nicopure Labs, Kovacevic spearheaded the challenge against the FDA’s “deeming rule,” showcasing her commitment to navigating complex regulatory landscapes.

Before her foray into the corporate sector, Kovacevic was a partner at Patton Boggs, where her breadth of expertise covered global nicotine and cannabis regulation, compliance, mergers and acquisitions, and a wide range of corporate affairs. She has also shared her insights as a board member of the Vapor Technology Association, serving on the advisory board of the Global Tobacco & Nicotine Forum, and as a member of the Society for Research on Nicotine and Tobacco (SRNT).

As an attorney admitted to practice in New York and before the Supreme Court of the United States, Kovacevic’s legal acumen is complemented by her academic achievements. She holds a Juris Doctor from Columbia Law School and an M.A. in Philology. Kovacevic is also an alumnus of the Harvard Business School “Corporate Leader” executive education program, further underscoring her leadership in the regulatory field.

A polyglot, her linguistic capabilities span Italian, French, Romanian, Serbian, Croatian, Spanish, and German, adding a global perspective to her professional endeavors. Patricia I. Kovacevic’s distinguished career is marked by her relentless pursuit of excellence in the legal and regulatory domains, making her a vital asset to the international regulatory community.